Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, Chersich M.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):35-41. doi: 10.1097/QAI.0b013e3181cf9979.

PMID:
20216425
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Abortion and the risk of subsequent preterm birth: a systematic review with meta-analyses.

Swingle HM, Colaizy TT, Zimmerman MB, Morriss FH Jr.

J Reprod Med. 2009 Feb;54(2):95-108. Review.

PMID:
19301572
[PubMed - indexed for MEDLINE]
3.

Association of low CD4 cell count and intrauterine growth retardation in Thailand.

Cailhol J, Jourdain G, Coeur SL, Traisathit P, Boonrod K, Prommas S, Putiyanun C, Kanjanasing A, Lallemant M; Perinatal HIV Prevention Trial Group.

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):409-13. doi: 10.1097/QAI.0b013e3181958560.

PMID:
19214117
[PubMed - indexed for MEDLINE]
4.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
[PubMed - indexed for MEDLINE]
5.

Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.

Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, Casteleyn S, Feiterna-Sperling C, Groeger S, Zaknun D; Multicenter Interdisciplinary Study Group Germany/Austria.

HIV Med. 2008 Jan;9(1):6-13. doi: 10.1111/j.1468-1293.2008.00520.x.

PMID:
18199167
[PubMed - indexed for MEDLINE]
6.

Epidemiology and causes of preterm birth.

Goldenberg RL, Culhane JF, Iams JD, Romero R.

Lancet. 2008 Jan 5;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4. Review.

PMID:
18177778
[PubMed - indexed for MEDLINE]
7.

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.

Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA.

AIDS. 2007 May 11;21(8):1019-26.

PMID:
17457096
[PubMed - indexed for MEDLINE]
8.

Preterm delivery risk in relation to maternal HIV infection, history of malaria and other infections among urban Zimbabwean women.

Noble A, Ning Y, Woelk GB, Mahomed K, Williams MA.

Cent Afr J Med. 2005 May-Jun;51(5-6):53-8.

PMID:
17432432
[PubMed - indexed for MEDLINE]
9.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.

PMID:
17353299
[PubMed - indexed for MEDLINE]
Free Article
10.

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.

Kourtis AP, Schmid CH, Jamieson DJ, Lau J.

AIDS. 2007 Mar 12;21(5):607-15. Review.

PMID:
17314523
[PubMed - indexed for MEDLINE]
11.

Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ.

J Infect Dis. 2006 May 1;193(9):1195-201. Epub 2006 Mar 28.

PMID:
16586354
[PubMed - indexed for MEDLINE]
Free Article
12.

Protease inhibitor use in 233 pregnancies.

Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):30-3.

PMID:
16123678
[PubMed - indexed for MEDLINE]
13.

Maternal infection and adverse fetal and neonatal outcomes.

Goldenberg RL, Culhane JF, Johnson DC.

Clin Perinatol. 2005 Sep;32(3):523-59. Review.

PMID:
16085019
[PubMed - indexed for MEDLINE]
14.

Nelfinavir and nevirapine side effects during pregnancy.

Timmermans S, Tempelman C, Godfried MH, Nellen J, Dieleman J, Sprenger H, Schneider ME, de Wolf F, Boer K, van der Ende ME; Dutch HMF Study Group.

AIDS. 2005 May 20;19(8):795-9.

PMID:
15867493
[PubMed - indexed for MEDLINE]
15.

Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.

Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, Hammill H, Landesman S, Zorrilla C, Thompson B; Women and Infants Transmission Study.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):449-73.

PMID:
15764963
[PubMed - indexed for MEDLINE]
16.

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe.

Thorne C, Patel D, Newell ML.

AIDS. 2004 Nov 19;18(17):2337-9.

PMID:
15577551
[PubMed - indexed for MEDLINE]
17.
18.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

PMID:
12063370
[PubMed - indexed for MEDLINE]
Free Article
19.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
[PubMed - indexed for MEDLINE]
20.

Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study.

Stratton P, Tuomala RE, Abboud R, Rodriguez E, Rich K, Pitt J, Diaz C, Hammill H, Minkoff H.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):179-86.

PMID:
10048906
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk